Aggressive angiomyxoma of uterine corpus

Authors

  • Rachitha Revanna Department of Obstetrics and Gynaecology Sapthagiri Institute of Medical Sciences and Research Centre
  • Padmasri Ramalingappa Department of Obstetrics and Gynaecology, Sapthagiri Institute of Medical Sciences and Research Centre, Bangalore, Karnataka, India
  • Divya Tumkur Kumar Department of Obstetrics and Gynaecology, Sapthagiri Institute of Medical Sciences and Research Centre, Bangalore, Karnataka, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20221689

Keywords:

Aggressive angiomyxoma, Mesenchymal tumor, Myxoid matrix

Abstract

Aggressive angiomyxoma (AA) is a rare slow growing mesenchymal tumour that preferentially involves the vulvovaginal, pelvic or perineal regions. It is called aggressive due its frequent local recurrences and infiltrative behavior. They occur most commonly in the reproductive age group in women. A 37 year old with AA of endometrial polyp, presenting with acute pain abdomen and friable, fleshy mass protruding out of introitus, precipitated by a dilatation and curettage for heavy menstrual bleeding. A clinical diagnosis of fibroid polyp with acute red degeneration was considered. There was a spontaneous expulsion of fleshy mass. HPE showed AA with features of torsion. MRI showed T2 heterogenous hyperintense mass lesion of 9 x 3 x 3.9 cm pedunculated polypoidal arising from upper anterior uterine wall. Hysterectomy specimen confirmed HPE findings of AA. Radiological studies and pathological evaluation aids in the diagnosis and planning of appropriate treatment of AA. Close and long term follow up of these patients should be emphasized due to high rate of local recurrence.

References

Elkattah R, Sarkodie O, Otteno H, Fletcher A. Aggressive angiomyxoma of the vulva: a précis for primary care providers. Case Rep Obstet Gynecol. 2013;2013:1-4.

Steeper TA, Rosai J. Aggressive angiomyxoma of the female pelvis and perineum. Report of nine cases of a distinctive type of gynecologic soft-tissue neoplasm. Am J Surg Pathol. 1983 [cited 2022;7(5):463-75.

Siassi RM, Papadopoulos T, Matzel KE. Metastasizing aggressive angiomyxoma. N Engl J Med. 1999;341(23):1772.

Kura MM, Jindal SR, Khemani UN. Aggressive angiomyxoma of the vulva: an uncommon entity. Indian Dermatol Online J. 2012;3(2):128.

Han-Geurts IJM, Geel AN, Doorn L, Bakker M, Eggermont AMM, Verhoef C. Aggressive angiomyxoma: multimodality treatments can avoid mutilating surgery. Eur J Surg Oncol. 2006;32(10):1217-21.

Blandamura S, Cruz J, Vergara L, Puerto I, Ninfo V. Aggressive angiomyxoma: a second case of metastasis with patient’s death. Hum Pathol. 2003;34(10):1072-4.

Alameda F, Munné A, Baró T, Iglesias M, Condom E, Lloreta-Trull J, et al. Vulvar angiomyxoma, aggressive angiomyxoma, and angiomyofibroblastoma: an immunohistochemical and ultrastructural study. Ultrastruct Pathol. 2006;30(3):193-205.

Nucci MR, Fletcher CDM. Vulvovaginal soft tissue tumours: update and review. Histopathology. 2000;36(2):97-108.

Allen PW, Dymock RB, MacCormac LB. Superficial angiomyxomas with and without epithelial components. Report of 30 tumors in 28 patients. Am J Surg Pathol. 1988;12(7):519-30.

Bégin LR, Clement PB, Kirk ME, Jothy S, Elliott McCaughey WT, Ferenczy A. Aggressive angiomyxoma of pelvic soft parts: a clinicopathologic study of nine cases. Hum Pathol. 1985;16(6):621-8.

Fletcher CDM, Tsang WYW, Fisher C, Lee KC, Chan JKC. Angiomyofibroblastoma of the vulva. A benign neoplasm distinct from aggressive angiomyxoma. Am J Surg Pathol. 1992;16(4):373-82.

Evans HL. Low-grade fibromyxoid sarcoma. A report of two metastasizing neoplasms having a deceptively benign appearance. Am J Clin Pathol. 1987;88(5):615-9.

Goldblum J, Weiss S, Folpe AL. Enzinger and Weiss’s Soft Tissue Tumors. 7th ed. Elsevier; 2019.

Outwater EK, Marchetto BE, Wagner BJ, Siegelman ES. Aggressive angiomyxoma: findings on CT and MR imaging. AJR Am J Roentgenol. 1999;172(2):435-8.

Behranwala KA, Thomas JM. Aggressive angiomyxoma: a distinct clinical entity. Eur J Surg Oncol. 2003;29(7):559-63.

McCluggage WG, Connolly L, McBride HA. HMGA2 is a sensitive but not specific immunohistochemical marker of vulvovaginal aggressive angiomyxoma. Am J Surg Pathol. 2010;34(7):1037-42.

Magtibay PM, Salmon Z, Keeney GL, Podratz KC. Aggressive angiomyxoma of the female pelvis and perineum: a case series. Int J Gynecol Cancer. 2006;16(1).

Downloads

Published

2022-06-27

Issue

Section

Case Reports